ERBB2 and breast cancer: The aim of this retrospective study was to investigate the changes in ER, PR and HER2 status in metastatic lesions compared with paired primary breast cancer, and to find changes in the treatment strategies after biopsy confirmation of recurrence with assessment of predictive markers in the patients with suspected breast cancer metastasis.